{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T17:49:53Z","timestamp":1794851393405,"version":"4.9.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"am","delay-in-days":295,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.drugalcdep.2025.112792","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:35:48Z","timestamp":1752712548000},"page":"112792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Exposures to synthetic cathinones, fentanyl, and xylazine among nightclub attendees in New York City, 2024"],"prefix":"10.1016","volume":"275","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8565-9415","authenticated-orcid":false,"given":"Joseph J.","family":"Palamar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7079-2003","authenticated-orcid":false,"given":"Nina","family":"Abukahok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E.","family":"Walton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna","family":"Stang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1775-1882","authenticated-orcid":false,"given":"Alex J.","family":"Krotulski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2025.112792_bib1","unstructured":"Abbott Laboratories., n.d. Quantisal\u2122 Oral Fluid Collection Device. \u3008https:\/\/www.toxicology.abbott\/us\/en\/products\/quantisal-oral-fluid-collection-device.html\u3009"},{"key":"10.1016\/j.drugalcdep.2025.112792_bib2","series-title":"Fentanyl death investigation in four Washington State counties","author":"Banta-Green","year":"2017"},{"key":"10.1016\/j.drugalcdep.2025.112792_bib3","unstructured":"Centers for Disease Control and Prevention, 2024. State unintentional drug overdose reporting system (SUDORS): final data. Available at: \u3008https:\/\/www.cdc.gov\/overdose-prevention\/data-research\/facts-stats\/sudors-dashboard-fatal-overdose-data.html\u3009 (accessed 3 February 2025)."},{"issue":"6","key":"10.1016\/j.drugalcdep.2025.112792_bib4","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.3390\/jcm13061812","article-title":"Sexualized drug use and chemsex among men who have sex with men in Europe: a systematic review and meta-analysis","volume":"13","author":"Coronado-Mu\u00f1oz","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.drugalcdep.2025.112792_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108962","article-title":"Prevalence of new psychoactive substances (NPS) in Brazil based on oral fluid analysis of samples collected at electronic music festivals and parties","volume":"227","author":"da Cunha","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2025.112792_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clinms.2020.10.003","article-title":"Analysis of 17 fentanyls in plasma and blood by UPLC-MS\/MS with interpretation of findings in surgical and postmortem casework","volume":"18","author":"Danaceau","year":"2020","journal-title":"Clin. Mass Spectrom."},{"issue":"6","key":"10.1016\/j.drugalcdep.2025.112792_bib7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/jat\/bkz048","article-title":"Oral fluid drug testing: analytical approaches, issues and interpretation of results","volume":"43","author":"Desrosiers","year":"2019","journal-title":"J. Anal. Toxicol."},{"issue":"23","key":"10.1016\/j.drugalcdep.2025.112792_bib8","doi-asserted-by":"crossref","first-page":"14619","DOI":"10.3390\/ijms232314619","article-title":"Molecular insights and clinical outcomes of drugs of abuse adulteration: new trends and new psychoactive substances","volume":"23","author":"Di Trana","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2-3","key":"10.1016\/j.drugalcdep.2025.112792_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.forsciint.2004.11.022","article-title":"Review: pharmacokinetics of illicit drugs in oral fluid","volume":"150","author":"Drummer","year":"2005","journal-title":"Forensic Sci. Int."},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112792_bib10","first-page":"147","article-title":"Drug testing in oral fluid","volume":"27","author":"Drummer","year":"2006","journal-title":"Clin. Biochem Rev."},{"key":"10.1016\/j.drugalcdep.2025.112792_bib11","series-title":"European drug report 2024: trends and developments","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2024"},{"key":"10.1016\/j.drugalcdep.2025.112792_bib12","unstructured":"European Monitoring Centre for Drugs and Drug Addiction, Europol, 2010. Europol\u2013EMCDDA joint report on a new psychoactive substance: 4-methylmethcathinone (mephedrone). Available at: https:\/\/www.europol.europa.eu\/cms\/sites\/default\/files\/documents\/march2010.pdf (accessed 3 February 2025)."},{"key":"10.1016\/j.drugalcdep.2025.112792_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2021.111083","article-title":"Analysis of drug residue in needle-exchange syringes in Washington, D.C","volume":"329","author":"Evans","year":"2021","journal-title":"Forensic Sci. Int"},{"key":"10.1016\/j.drugalcdep.2025.112792_bib14","article-title":"Drug overdose deaths in the United States, 2003\u20132023","volume":"522","author":"Garnett","year":"2024"},{"issue":"26","key":"10.1016\/j.drugalcdep.2025.112792_bib15","doi-asserted-by":"crossref","first-page":"721","DOI":"10.15585\/mmwr.mm7226a4","article-title":"Illicitly manufactured fentanyl-involved overdose deaths with detected xylazine - United States, January 2019-June 2022","volume":"72","author":"Kariisa","year":"2023","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"37","key":"10.1016\/j.drugalcdep.2025.112792_bib16","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.15585\/mmwr.mm7037a4","article-title":"Notes from the field: xylazine detection and involvement in drug overdose deaths - United States, 2019","volume":"70","author":"Kariisa","year":"2021","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"8","key":"10.1016\/j.drugalcdep.2025.112792_bib17","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/jat\/bky051","article-title":"The detection of novel stimulants in oral fluid from users reporting ecstasy, Molly and MDMA ingestion","volume":"42","author":"Krotulski","year":"2018","journal-title":"J. Anal. Toxicol."},{"issue":"3","key":"10.1016\/j.drugalcdep.2025.112792_bib18","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/jat\/bkx105","article-title":"Field detection of drugs of abuse in oral fluid using the Alere\u2122 DDS\u00ae2 Mobile Test System with confirmation by liquid chromatography tandem mass spectrometry (LC-MS\/MS)","volume":"42","author":"Krotulski","year":"2018","journal-title":"J. Anal. Toxicol."},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112792_bib19","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/1556-4029.14184","article-title":"Sample mining and data mining: combined real-time and retrospective approaches for the identification of emerging novel psychoactive substances","volume":"65","author":"Krotulski","year":"2020","journal-title":"J. Forensic Sci."},{"issue":"6","key":"10.1016\/j.drugalcdep.2025.112792_bib20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/jat\/32.6.393","article-title":"Drug testing in oral fluid-evaluation of sample collection devices","volume":"32","author":"Langel","year":"2008","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2025.112792_bib21","article-title":"Temporal and spatial trends of fentanyl co-occurrence in the illicit drug supply in the United States: a serial cross-sectional analysis","volume":"39","author":"Lim","year":"2024","journal-title":"Lancet Reg. Health Am."},{"issue":"5","key":"10.1016\/j.drugalcdep.2025.112792_bib22","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/jat\/bkaa104","article-title":"Evaluating trends in novel psychoactive substances using a sentinel population of electronic dance music festival attendees","volume":"45","author":"Mohr","year":"2020","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2025.112792_bib23","unstructured":"NPS Discovery, 2024. NPS stimulants & hallucinogens in the United States."},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112792_bib24","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/phn.13193","article-title":"Awareness that cocaine can contain fentanyl among nightclub and festival attendees in New York City, 2018-2022","volume":"40","author":"Palamar","year":"2023","journal-title":"Public Health Nurs."},{"key":"10.1016\/j.drugalcdep.2025.112792_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104001","article-title":"Trends in drug use among nightclub and festival attendees in New York City, 2017-2022","volume":"115","author":"Palamar","year":"2023","journal-title":"Int J. Drug Policy"},{"issue":"9","key":"10.1016\/j.drugalcdep.2025.112792_bib26","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1080\/15563650.2023.2273770","article-title":"Trends and correlates of discordant reporting of drug use among nightclub\/festival attendees, 2019-2022","volume":"61","author":"Palamar","year":"2023","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.drugalcdep.2025.112792_bib27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.drugpo.2017.07.010","article-title":"Hair testing to assess both known and unknown use of drugs amongst ecstasy users in the electronic dance music scene","volume":"48","author":"Palamar","year":"2017","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2025.112792_bib29","article-title":"Trends in reported and biologically confirmed drug use among people who use ecstasy in the nightclub\/festival-attending population, 2016-2022","volume":"9","author":"Palamar","year":"2023","journal-title":"Drug Alcohol Depend. Rep."},{"key":"10.1016\/j.drugalcdep.2025.112792_bib30","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.drugalcdep.2016.02.001","article-title":"Detection of \"bath salts\" and other novel psychoactive substances in hair samples of ecstasy\/MDMA\/\"Molly\" users","volume":"161","author":"Palamar","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2025.112792_bib31","unstructured":"Papsun, D.M., Mohr, A.L.A., Browne, T., Logan, B.K., 2024. Para-fluorofentanyl adulterating the illicit drug supply. NPS Discovery. Center for Forensic Science Research and Education, United States. Available at: \u3008https:\/\/www.cfsre.org\/images\/content\/reports\/public_alerts\/pFF_Public_Health_Alert_Final.pdf\u3009 (accessed 3 February 2025)."},{"key":"10.1016\/j.drugalcdep.2025.112792_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108416","article-title":"Fentanyl and fentanyl analogs in the illicit stimulant supply: results from U.S. drug seizure data, 2011-2016","volume":"218","author":"Park","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2025.112792_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2023.104154","article-title":"Xylazine in the drug supply: Emerging threats and lessons learned in areas with high levels of adulteration","volume":"120","author":"Quijano","year":"2023","journal-title":"Int. J. Drug Policy"},{"issue":"1","key":"10.1016\/j.drugalcdep.2025.112792_bib34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.23907\/2017.004","article-title":"Emerging synthetic fentanyl analogs","volume":"7","author":"Schueler","year":"2017","journal-title":"Acad. Forensic Pathol."},{"issue":"7","key":"10.1016\/j.drugalcdep.2025.112792_bib35","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/jat\/bkt054","article-title":"Scientific Working Group for Forensic Toxicology (SWGTOX) standard practices for method validation in forensic toxicology","volume":"37","year":"2013","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.drugalcdep.2025.112792_bib36","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-1-0716-3541-4_25","article-title":"Quantification of fentanyl and norfentanyl in whole blood using liquid chromatography-tandem mass spectrometry","volume":"2737","author":"Shell","year":"2024","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.drugalcdep.2025.112792_bib37","series-title":"National Forensic Laboratory Information System: NFLIS-Drug 2022 annual report","author":"U.S. Drug Enforcement Administration","year":"2023"},{"issue":"4","key":"10.1016\/j.drugalcdep.2025.112792_bib38","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/jat\/bkab032","article-title":"Phenethyl-4-ANPP: a marginally active byproduct suggesting a switch in illicit fentanyl synthesis routes","volume":"46","author":"Vandeputte","year":"2022","journal-title":"J. Anal. Toxicol."},{"issue":"2","key":"10.1016\/j.drugalcdep.2025.112792_bib39","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00007691-200404000-00020","article-title":"Detection times of drugs of abuse in blood, urine, and oral fluid","volume":"26","author":"Verstraete","year":"2004","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.drugalcdep.2025.112792_bib40","series-title":"Chloromethcathinone\u2014NPS Discovery new drug monograph","author":"Walton","year":"2024"},{"key":"10.1016\/j.drugalcdep.2025.112792_bib41","unstructured":"World Health Organization, 2023. Critical review report: 3-Chloromethcathinone. Expert Committee on Drug Dependence Forty-sixth meeting. Available at: https:\/\/cdn.who.int\/media\/docs\/default-source\/46th-ecdd\/3-cmc_46th-ecdd-critical-review_public-version.pdf?sfvrsn=d6e893bf_1 (accessed 3 February 2025)."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871625002455?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871625002455?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T03:38:19Z","timestamp":1767843499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871625002455"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":40,"alternative-id":["S0376871625002455"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112792","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exposures to synthetic cathinones, fentanyl, and xylazine among nightclub attendees in New York City, 2024","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2025.112792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112792"}}